Trading IdeasFundamentals

JFL Life Sciences Limited

NSE: JFLLIFE · Other · sector

₹10.30NSE close 2026-10-22

Key numbers

Market cap₹34 cr
Price₹10.30
52w high / low₹15 / ₹9
P/E5.0xSector median 14.4x
P/B0.7xSector median 1.7x
Book value₹13.9
Dividend yield–Sector median 0.37%
ROE15.9%Sector median 13.8%
ROCE16.0%Sector median 19.6%
OPM9.1%Sector median 10.4%
Debt / equity0.47xSector median 0.29x
EV/EBITDA4.6xSector median 8.4x
Interest cover5.0x
Current ratio1.73x
Sales growth 3y+45.3%Sector median +7.7%
Profit growth 3y+31.6%Sector median +16.6%
PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹66.70 · low ₹8.95
Sep 2024May 2025Oct 2025Apr 2026Oct 2026

Quarterly results

₹ crMar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue2749331230276311
EBITDA25323342
OPM %7.8%11.1%8.3%16.7%9.8%12.5%5.6%18.8%
Other income00000000
Net profit23112221
EPS (₹)2.103.060.240.230.600.610.500.34
Revenue YoY+9.6%-45.3%+91.1%-4.2%
Profit YoY-14.3%-39.3%+107.5%+48.0%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY23FY24FY25FY26TTM
Revenue434782131131
EBITDA4581212
Net profit34467
EPS (₹)2.903.011.261.942.05
Revenue growth+8.7%+76.2%+60.1%–
Profit growth+24.9%+18.5%+53.8%–
Dividend / share (₹)––––
Compounded growth3 years5 yearsLast 12 months
Sales+45.3%––
Net profit+31.6%––
EPS-12.5%––
Share price–-33.7% (2y)-16.3%

Balance sheet

₹ crFY23FY24FY25FY26
Shareholders' equity––3946
Borrowings––1122
Cash & equivalents––01
Total assets––72106
Fixed assets––1215
Investments––00
Receivables––3553
Inventory––2335
Payables––1829

Year-end figures from the March annual filing.

Cash flow

₹ crFY23FY24FY25FY26
Cash from operations-98-4-4
Cash from investing1-6-0-4
Cash from financing8-249
Capex0003
Free cash flow-98-4-8

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY23FY24FY25FY26
ROE %––10.5%14.0%
ROCE %––14.4%15.8%
Debtor days––155148
Inventory days––128110
Payable days––9893
Cash conversion cycle (days)––185165
Working capital days––124107

Peers in Other

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
TSFINV₹8,585 cr17.6x1.4x8.4%3.6%20.5%+121.7%2.30%
KRISHANA₹6,339 cr39.9x11.3x41.6%23.2%12.6%+95.7%0.05%
MARINE₹5,431 cr84.2x11.0x14.3%18.0%10.8%+25.6%0.07%
ZOTA₹4,139 cr–6.0x-22.5%-12.4%-0.5%+56.7%0.07%
AIMTRON₹3,319 cr71.7x17.1x28.0%31.8%21.8%––
ACCORD₹2,984 cr–261.7x12.4%12.0%2.4%––
MONOLITH₹2,646 cr64.6x24.3x36.0%48.7%24.4%––
UTSSAV₹2,390 cr40.2x14.1x43.4%54.7%7.9%––
BETA₹2,200 cr40.6x5.0x16.4%17.0%20.8%––
JFLLIFE₹34 cr5.0x0.7x15.9%16.0%9.1%+45.3%–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company

Sector
IndustryOther
Sub-industry
SymbolJFLLIFE
BSE code–
ISININE0LA901015
Face value₹10.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-22.